Clinical Trial Update: A Study to Assess the Effect of Abiraterone Acetate in Male Participants With Mild or Moderate Hepatic Impairment Compared to Matched Control Participants With Normal Hepatic Function [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacokinetics of abiraterone acetate in men with mild or moderate hepatic impairment compared with matched controls with normal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Zytiga (abiraterone acetate)

Snippet

Sponsor: Cougar Biotechnology, Inc. | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED